10 June Swiss Growth Forum Call Notes laser foc
Post# of 30028
(Total Views: 556)
Posted On: 06/10/2020 11:59:46 AM
.jpg)
10 June Swiss Growth Forum Call Notes
laser focused on covid
lympro data in near future
lots of progress in cancer area
some clients(labs) looking to scale from 1000 to 15000 tests per day
world is waking up to need for testing, especially outside US
talks about "existing customers"
says in talks with a health network partnership
roche stuggling to meet volume. clients like nursing homes, goverment, urgent care centers upset and backlogged. so local labs key
they're finalizing partnerships right now
camps, return to school testing,
focused on doing small pilots with partners so they can scale quickly in fall
trials ongoing now with several health systems. working on logistics
mass testing to follow with partnerships
big essential services, ie nuclear power plants, etc can't take much risk so they are overkill to minimize risk
lab side vs sample collection side
putting additional partnerships in place to scale nationally
working on 1step PCR
they are taking the gnomegen tests to FDA
very pleased with the antibody test data. their validation data is in line with manufactures, 2/3 completed. shaghai sen/spec 100/97.5 gensur 100/95
they're turning away business from the lab, mostly from new york
focused on scaling
will update soon "near future" and on big revenue milestones. sales right now are smaller scale, validating and set up. on revenue, waiting to get second purchases from clients to know it's solid before reporting.
found a key solution
won't publish PCR validation data until it's through the FDA
F-1 and audit nearly done, pleased, coming soon. not clear if they're going to actually need to raise money pre uplist. uplist soon still plan
several announcements to come in next few weeks they think market will be very receptive too
had a client call so hopped off to complete. answered a few Q's
laser focused on covid
lympro data in near future
lots of progress in cancer area
some clients(labs) looking to scale from 1000 to 15000 tests per day
world is waking up to need for testing, especially outside US
talks about "existing customers"
says in talks with a health network partnership
roche stuggling to meet volume. clients like nursing homes, goverment, urgent care centers upset and backlogged. so local labs key
they're finalizing partnerships right now
camps, return to school testing,
focused on doing small pilots with partners so they can scale quickly in fall
trials ongoing now with several health systems. working on logistics
mass testing to follow with partnerships
big essential services, ie nuclear power plants, etc can't take much risk so they are overkill to minimize risk
lab side vs sample collection side
putting additional partnerships in place to scale nationally
working on 1step PCR
they are taking the gnomegen tests to FDA
very pleased with the antibody test data. their validation data is in line with manufactures, 2/3 completed. shaghai sen/spec 100/97.5 gensur 100/95
they're turning away business from the lab, mostly from new york
focused on scaling
will update soon "near future" and on big revenue milestones. sales right now are smaller scale, validating and set up. on revenue, waiting to get second purchases from clients to know it's solid before reporting.
found a key solution
won't publish PCR validation data until it's through the FDA
F-1 and audit nearly done, pleased, coming soon. not clear if they're going to actually need to raise money pre uplist. uplist soon still plan
several announcements to come in next few weeks they think market will be very receptive too
had a client call so hopped off to complete. answered a few Q's
(6)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼